GSA Capital Partners’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.29M	Sell	178,301 -54,779	-24%	-$698K	0.14%	120
2025 Q4	$2.1M	Buy	233,080 +157,989	+210%	+$2.17M	0.18%	73
2025 Q3	$1.3M	Sell	75,091 -109,292	-59%	-$1.35M	0.11%	255
2025 Q2	$1.73M	Sell	184,383 -35,535	-16%	-$292K	0.12%	176
2025 Q1	$1.56M	Buy	219,918 +133,577	+155%	+$1.35M	0.14%	147
2024 Q4	$1.01M	Buy	+86,341	New	+$1.35M	0.07%	402
2024 Q3	–	Sell	-70,355	Closed	-$1.57M	–	1889
2024 Q2	$1.57M	Buy	+70,355	New	+$1.68M	0.11%	248
2023 Q1	–	Sell	-14,355	Closed	-$501K	–	1794
2022 Q4	$501K	Buy	14,355 +3,948	+38%	+$188K	0.06%	602
2022 Q3	$582K	Buy	+10,407	New	+$646K	0.08%	459
2020 Q1	–	Sell	-33,533	Closed	-$492K	–	1398
2019 Q4	$492K	Buy	+33,533	New	+$467K	0.06%	660
2019 Q3	–	Sell	-30,555	Closed	-$500K	–	1611
2019 Q2	$500K	Buy	30,555 +20,181	+195%	+$317K	0.06%	668
2019 Q1	$177K	Buy	+10,374	New	+$155K	0.02%	1263
2018 Q2	–	Sell	-51,900	Closed	-$1.09M	–	1854
2018 Q1	$1.09M	Buy	+51,900	New	+$1.28M	0.06%	596
2017 Q4	–	Sell	-73,100	Closed	-$1.82M	–	1737
2017 Q3	$1.82M	Buy	73,100 +16,400	+29%	+$309K	0.12%	182
2017 Q2	$907K	Buy	+56,700	New	+$792K	0.06%	638